Sumapan 50 Tablet contains Sumatriptan 50mg, a selective serotonin receptor agonist used for acute treatment of migraine attacks with or without aura. It provides fast relief from headache, nausea, vomiting, and light/sound sensitivity associated with migraine episodes.
By stimulating serotonin (5-HT1) receptors in cranial blood vessels, Sumatriptan reduces vascular inflammation and blocks pain pathways, offering effective symptomatic relief. It is designed for rapid onset and targeted migraine management.
Belonging to the neurology and CNS therapeutic segment, Sumapan 50 Tablet is widely prescribed by neurologists and general physicians. Its acute-use profile and patient demand make it a high-value product in hospitals, clinics, and retail pharmacies.
For PCD pharma franchise partners, distributors, and exporters, Sumapan 50 Tablet presents a lucrative opportunity in the migraine care market. It is available for bulk supply, third-party manufacturing, private-label branding, and institutional orders across India, ensuring strong repeat demand and stable business growth.